– By being a large consortium, we have been able to make substantial progress. It is not enough to apply one or two or three methods, you really need a concerted effort. By using the same antibody, we can compare and triangulate results – which is impossible if you do one experiment on one antibody, and the other experiment on a different antibody, or on the same antibody under slightly different conditions, says Anna Stradner.
Experiments to elucidate and predict antibody behavior
The different research groups have performed X-ray, neutron, and light scattering experiments and applied various complementary techniques covering a huge range of length and time scales to gain more knowledge on antibody flow behavior, interactions between antibodies and antibody stability. The consortium has also been producing theoretical models to predict antibody behavior under various solution conditions. Here the specific structure of antibodies, which is Y-shaped, has added another level of complexity to their work.
– The goal has been to reach a level of understanding where you can make predictions from the molecular structure of a single antibody without having to go through the elaborate production steps involved in finding out how it will behave at high concentrations, which is both time consuming and very expensive, says Anna Stradner.
She continues:
– Our results can be of great use for pharmaceutical industry as they are developing new treatments, since they can predict important knowledge on flow behaviour, solution stability and turbidity of antibodies in solution.
The antibody final meeting: a time for both closure and new beginnings
Anna Stradner is now looking forward to discuss the consortium’s results and their implications at the upcoming final Antibody meeting in September, including from an industrial viewpoint – both with consortium members and other researchers.
The event will comprise both presentations and interaction, including a round-table discussion at the end. Anna Stradner notes that she is very much looking forward to the outcomes of these discussions.
– I hope to see many questions from people outside our consortium. They might think about things we have completely missed, and bring a fresh view. I also expect that it will show still existing gaps in our understanding, and it will hopefully also lead to in-depth discussions of future steps beyond the program.
– We will also discuss how to make our experimental data and the modeling and analysis programs available for the community. At the end, the intention of our program was always to create a true reference data set that can be used not only by the consortium members but by the international community for future work. We also hope that the meeting will inspire other people to launch similar bottom-up actions and utilize LINXS for this purpose.
She is also curious to see if the meeting might spark new collaboration and approaches to the area.
– We certainly want to continue since our work is by no means finished! Discussing how, and in what format will be a big part of the roundtable discussions!
Read more and register to the Antibody final meeting, 25 – 26th of September.